NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-241-2016-0-DE-01 Micro-Dose Calibrator DE EP 18779123.1 Issued
NCI E-241-2016-0-FR-01 Micro-Dose Calibrator FR EP 18779123.1 Issued
NCI E-241-2016-0-EP-05 Micro-Dose Calibrator EP National Stage 18779123.1 Issued
NCI E-241-2016-0-CH-01 Micro-Dose Calibrator CH EP 18779123.1 Issued
NCI E-241-2016-0-GB-01 Micro-Dose Calibrator GB EP 18779123.1 Issued
NCI E-229-2018-0-US-03 AZA-A-RING INDENOISOQUINOLINE TOPOISOMERASE I POISONS US National Stage 16/081,959 10759795 Issued PDF
NCI E-241-2016-0-PCT-02 Micro-Dose Calibrator PCT PCT PCT/US2018/049399 Expired
NCI E-105-2012-0-HK-12 Murine Anti-NY-ESO-1 T Cell Receptors HK National Stage 18111203.0 Issued
NCI E-105-2012-0-US-14 MURINE ANTI-NY-ESO-1 T CELL RECEPTORS US DIV 16/115,969 10407485 Issued PDF
NEI E-164-2018-1-US-01 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS US 62/724,480 Abandoned
NCATS E-232-2017-0-EP-04 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders EP National Stage 18852438.3 Issued
NCATS E-232-2017-0-JP-07 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders JP National Stage 2020-512001 Issued
NCATS E-232-2017-0-EA-09 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders EA National Stage 202090521 Issued
NCATS E-232-2017-0-US-03 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders US National Stage 16/642,445 11459320 Issued PDF
NCATS E-232-2017-0-PCT-02 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders PCT PCT PCT/US2018/048339 Expired
NCATS E-232-2017-0-CN-13 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders CN National Stage 2018800656534 Pending
NCATS E-232-2017-0-KR-11 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders KR National Stage 10-2020-7008731 Pending
NCATS E-232-2017-0-MX-08 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders MX National Stage MX/a/2020/002196 Pending
NCATS E-232-2017-0-AU-10 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders AU National Stage 2018323443 Pending
NCATS E-232-2017-0-BR-05 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders BR National Stage BR112020004116-5 Pending
NCATS E-232-2017-0-CA-06 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders CA National Stage 3074110 Pending
NIDCR E-092-2019-0-US-01 Biomarkers, COmpositions, And Methods For Diagnosing And Treating Subjects Exposed To Protein/Herparin Complexes US 62/723,720 Abandoned
NCATS E-232-2017-0-IN-12 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders IN National Stage 202027012300 Pending
NHLBI E-222-2022-5-EP-01 Catheters and Manipulators with Articulable Ends EP National Stage 18848165.9 Pending
NHLBI E-222-2022-5-PC-01 Catheters and Manipulators with Articulable Ends PCT PCT COMB PCT/US2018/048177 Expired
NCI E-146-2018-0-US-01 CAR T-cells Targeting CAIX For Glioblastoma Therapy US 62/722,959 Abandoned
NCI E-143-2017-0-JP-05 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range JP National Stage 2020-510560 Issued
NIAID E-106-2016-0-US-04 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE US National Stage 16/079,972 11191821 Issued PDF
NCI E-143-2017-0-NL-10 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range NL EP 18765321.7 Issued
NCI E-143-2017-0-CH-07 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range CH EP 18765321.7 Issued
NCI E-143-2017-0-GB-09 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range GB EP 18765321.7 Issued
NCI E-143-2017-0-SE-11 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range SE EP 18765321.7 Issued
NCI E-143-2017-0-EP-04 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range EP National Stage 18765321.7 Issued
NCI E-143-2017-0-DE-08 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range DE EP 18765321.7 Issued
NHGRI E-217-2007-0-JP-16 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP DIV 2018-156853 Issued
NCI E-143-2017-0-PCT-02 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range PCT PCT PCT/US2018/047876 Expired
NIAID E-236-2018-0-PCT-02 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof PCT PCT PCT/KR2018/009754 Expired
NCI E-139-2018-0-US-01 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING US 62/721,986 Abandoned
NCI E-055-2011-0-US-05 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE US DIV 16/107,559 11357839 Issued PDF
NCI E-015-2011-0-US-12 NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER US DIV 16/107,532 10737995 Issued PDF
NCI E-291-2012-0-US-17 M971 CHIMERIC ANTIGEN RECEPTORS US DIV 16/107,271 10703816 Issued PDF
NEI E-077-2018-0-US-01 Metabolic Regulation Of Mitochondria To Inhibit Inflammatory Microglia In Treatment Of Axonal Injury And Neurodegenerations US 62/720,612 Abandoned
NEI E-165-2017-0-CN-03 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES CN National Stage 201880068155.5 Issued
NEI E-165-2017-0-PCT-02 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES PCT PCT PCT/US2018/047064 Expired
NCI E-767-2013-0-US-08 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules US CON 16/105,425 Abandoned
NIBIB E-006-2016-0-FR-09 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy FR EP 17844356.0 Issued
NIBIB E-006-2016-0-DE-08 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy DE EP 17844356.0 Issued
NIBIB E-006-2016-0-GB-10 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy GB EP 17844356.0 Issued
NIBIB E-006-2016-0-CH-07 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy CH EP 17844356.0 Issued
NIBIB E-006-2016-0-EP-03 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy EP National Stage 17844356.0 Issued